This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
egln1
EGLN1
EGLN1 (PHD2) is the principal prolyl hydroxylase that marks HIF-1α/2α for VHL-mediated ubiquitination under normoxia; EGLN1 uses O₂ as cosubstrate — inactivated by hypoxia → HIF stabilized; PHD inhibitors (daprodustat, vadadustat) block EGLN1 to treat CKD anemia.
Entry Metadata
| Field | Value |
|---|---|
| ID | egln1 |
| Name | EGLN1 |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 03-molecular |
Cross-Atlas Connections
Sources
- Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107(1):43-54. · PubMed 11595184
- Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30(4):393-402. · PubMed 18498744